http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103239730-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103239730-B
titleOfInvention Medical sodium alginate gel microsphere and preparation method and application thereof
abstract The invention provides a medical sodium alginate gel microsphere and a preparation method and application of the medical sodium alginate gel microsphere. The medical sodium alginate gel microsphere consists of a composite medicine carrier and a water-insoluble medicine; the medicine is coated with the composite medicine carrier; and the composite medicine carrier is an ion crosslinking agent-sodium alginate-divalent metal ion, wherein the ion crosslinking agent is 4-aminomethylbenzoic acid or tranexamic acid. The preparation method comprises the following steps of: (1) mixing ion crosslinking agent aqueous solution with divalent metal ion solution in the same volume to obtain composite solidifying liquid; (2) dispersing medicine powder or an agent into sodium alginate aqueous solution; uniformly mixing; dropwise adding the mixture into the composite solidifying liquid obtained in step (1) through a high-voltage static droplet generating device or a syringe needle, so that the mixture drops are solidified into spheres; and (3) dehydrating gel microspheres which are washed with the distilled water; and drying at normal temperature. The medical sodium alginate gel microsphere can be used for treating tuberculosis, endocrine disease and tumor, and also can be used for treating local acute hemorrhage and chronic errhysis.
priorityDate 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433321579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450984220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135659016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5102882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457619940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426067844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396423
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID292385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496039
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID292385

Total number of triples: 37.